The interleukin-6 -147 G/C polymorphism is associated with increased risk of coronary artery disease in young South African Indian men

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 3, 2013, Pages 205-209

  Phulukdaree, Alisa ^a   Khan, Sajidah ^a   Ramkaran, Prithiksha ^a   Govender, Rishalan ^a   Moodley, Devapregasan ^a   Chuturgoon, Anil A ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENATURATION; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SOUTH AFRICA; YOUNG ADULT;

EID: 84877868124     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0130     Document Type: Article

References (23)

1. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
2. Lubrano V, Cocci F, Battaglia D, et al. Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2009; 19;110-114.
3. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209-214.
4. Stenvikel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF: Central factors in the altered cytokine network of uremia-The good, the bad, and the ugly. Kidney Int 2005;67:1216-1233.
5. Olivieri F, Bonafe M, Cavallone L, et al. The 2174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp Gerontol 2002;37:309-314.
6. Yeh KY, Li YY, Hsieh LL, et al. The 2174G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol 2010;30:53-59.
7. Pereira DS, Garcia DM, Narciso FM, et al. Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly women. Braz J Med Biol Res 2011;44:123-129.
8. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
9. Kiszel P, Mako V, Prohaszka Z, et al. Interleukin-6-174 promoter polymorphism does not influence IL-6 production after LPS and IL-1 beta stimulation in human umbilical cord vein endothelial cells. Cytokine 2007;40:17-22.
10. Ray A, LaForge KS, Sehgal PB. On the mechanism for efficient repression of the interleukin-6 promoter by glucocor-ticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 1990;10:5736-5746.
11. Ivanova M, Ruiqing J, Kawai S, et al. IL-6 SNP diversity among four ethnic groups as revealed by bead-based liquid array profiling. Int J Immunogenet 2011;38:17-20.
12. Ujcic-Voortman JK, Baan CA, Verhoeff AP, et al. Ethnic differences in systemic inflammation: An investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. Atherosclerosis 2011;218: 220-225.
13. Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002;53:1029-1034.
14. Niu W, Liu Y, Qi Y, et al. Association of interleukin-6 circulating levels with coronary artery disease: A meta-analysis implementing mendelian randomization approach. Int J Cardiol 2012;157:243-252.
15. Maitra A, Shanker J, Dash D, et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease-the Indian Atherosclerosis Research Study. Thromb Haemost 2008;99:944-950.
16. Schuett H, Luchtefeld M, Grothusen C, et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 2009;102:215-222.
17. Shanker J, Kakkar VV. Implications of genetic polymorphisms in inflammation-induced atherosclerosis. Open Car-diovasc Med J 2010;4:30-37.
18. Brull DJ, Montgomery HE, Sanders J, et al. Interleukin-6 gene-174gc and-572gc promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-1463.
19. Liu Y, Bernard HU, Apt D. NFI-B3, a novel transcrip-tional repressor of the nuclear factor I family, is generated by alternative RNA rrocessing. J Biol Chem 1997;272:10739-10745.
20. Sie MPS, Sayed-Tabatabaei FA, Oei HHS, et al. Interleukin 6-174 G/C promoter polymorphism and risk of coronary heart disease. Arterioscler Thromb Vasc Biol 2006;26: 212-217.
21. Margaglione M, Bossone A, Cappucci G, et al. The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica 2001;86:199-204.
22. Ferroni P, Rosa A, Di Franco M., et al. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Clin Chim Acta 2007;381:151-156
23. Xu WD, Zhang YJ, Pan HF. Targeting IL-6 promoter polymorphism-174G/C should be dependent on ethnicity. Clin Rheumatol 2012;31:191-192.